Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

06 January 2004

Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B™ vaccine

Kazimierz Madaliński, Staffan P.E. Sylvan, Ulla Hellström, Jolanta Mikołajewicz, Katarzyna Dzierżanowska-Fangrat

Med Sci Monit 2004; 10(1): PI10-17 :: ID: 11551

Abstract

Background:An advantage of the third-generation HBV vaccines containing preS1 and preS2 antigens was suggested by their excellent immunogenicity in humans and the rapid onset of antibody response to the S-protein of the vaccine. Sequential studies of the antibody responses to the preS1 and preS2 in relation to the anti-HBs response after immunization with preS-containing vaccines have been made in older children only.Material/Methods: Twenty-eight randomly selected, healthy newborns received either 2.5 Kg or 5 Kg of Bio-Hep-B™ (preS1, 2+S) vaccine. The children received 3 doses of vaccine according to a 0, 1, 6 months scheme. Antibodies were determined at months 6 and 9.Results: The vaccine was well tolerated and safe in newborns. Seroconversion and seroprotection were achieved in 100% of newborns after the second injection. No dose-related effect on the anti-HBs response could be observed; GMTs of anti-HBs antibodies after the 2.5 Kg and 5.0 Kg doses were 6703 and 7104 Kg IU/l, respectively. The induction of measurable levels of antibodies towards preS1- and/or preS2-antigens with 2.5 Kg and 5 Kg doses of the vaccine was noted in 29% and 50% of the newborns, respectively, at 6 and/or 9 months of vaccination. An augmented anti-HBs response was elicited in the newborns who produced anti-preS2 after vaccination with 2.5 Kg compared with 5.0 Kg of the vaccine.Conclusions: The vaccine Bio-Hep-B™ can elicit high titers of anti-HBs antibodies in newborns after only two injections. The response of newborns was directed against preS1 + preS2, or preS2 alone.

Keywords: Hepatitis B Antibodies - blood, Hepatitis B Surface Antigens - immunology, Hepatitis B Vaccines - administration & dosage, Hepatitis B Vaccines - adverse effects, Hepatitis B Vaccines - immunology, Immunization Schedule, Infant, Newborn, Protein Precursors - immunology, Hepatitis B Antibodies - blood, Hepatitis B Surface Antigens - immunology, Hepatitis B Vaccines - immunology, Immunization Schedule, Infant, Newborn, Protein Precursors - immunology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750